Highlights d Astroglia menin deficiency leads to depressive-like behaviors in mice d Menin reduction in astrocytes promotes IL-1b generation through NF-kB activation d NF-kB and IL-1b inhibitors attenuate the depressive-like phenotypes d A MEN1 SNP associated with MDD risk leads to aberrant NF-kB activation SUMMARY
In Brief
Mechanisms underlying astrocytemediated neuroinflammation in depression remain unclear. Menin regulates NF-kB activity in astrocytes to promote neuroinflammation. Clinically, a MEN1 SNP is associated with the onset of depression. This study reveals a distinct role for menin in neuroinflammation and depression.
INTRODUCTION
Major depressive disorder (MDD) affects approximately 16% of the population and has become the main cause of disability worldwide (CONVERGE consortium, 2015; Ferrari et al., 2013) . Despite the high prevalence of this disorder, mechanisms underlying MDD risk remain elusive. MDD is characterized by mood despondency, disinterest, loss of concentration, and increased propensity for suicidal thoughts (Canals et al., 2002) . MDD was initially speculated to be a neuropsychiatric disease derived from neuronal dysfunction (Manji et al., 2001) . However, numerous studies have now implicated astrocyte dysfunction in the pathogenesis of MDD (Rajkowska and Stockmeier, 2013; Sanacora and Banasr, 2013; Wang et al., 2017) . As the most abundant glial cell type in the mammalian brain, astrocytes produce pro-inflammatory cytokines such as interleukin (IL)-1b, which are key to the induction of depressive symptoms in MDD (Koo and Duman, 2009; Norman et al., 2010) . As a pro-inflammatory transcriptional activator, nuclear factor-kB (NF-kB) is a critical regulator of inflammation in the central nervous system (CNS) (Baltimore, 2011; Oeckinghaus and Ghosh, 2009 ); however, the pathogenic driver of NF-kB-dependent pro-inflammatory activation in astrocytes during MDD onset remains unclear.
Recent studies suggest that dysregulation of genes residing within the chromosome 11q13.1 locus can mediate abnormal NF-kB activation (Parker et al., 2014) . In support of this, chromosomal micro-deletion of 11q13.1 was detected in a patient diagnosed with mental retardation (Gimelli et al., 2011) . Among the 12 genes deleted in 11q13.1, the multiple endocrine neoplasia type 1 gene (MEN1; encoding the protein menin) was of particular interest. Loss-of-function MEN1 gene mutations are causal to MEN1 syndrome, which is a dominantly inherited disease characterized by tumor formation in endocrine organs (Matkar et al., 2013) . MEN1 patients also feature neurological irregularities such as depression (Aoki et al., 1997) . As a scaffold component of nuclear protein complexes, menin has been shown to modulate gene expression and cell signaling during tumorigenesis (Heppner et al., 2001; Matkar et al., 2013) , potentially through interactions with the p65 NF-kB subunit (Gang et al., 2013; Heppner et al., 2001) . Although menin is ubiquitously expressed, its function differs according to tissue and cell type (Fang et al., 2013; Matkar et al., 2013) . However, a function for menin in the CNS has been largely unexplored.
Here, we provide strong evidence that menin deficiency increases NF-kB-induced IL-1b levels in astroglia to promote inflammation and associated onset of depressive-like phenotypes. A SNP associated with MEN1 (rs375804228) is linked to NF-kB hyper-activation and MDD susceptibility. Together, our results reveal a distinct role for the tumor suppressor menin in regulating astroglial inflammation in depressive disorders.
RESULTS
Menin Levels Are Attenuated in Mouse Brain after CUMS and LPS Exposure Chronic stress and neuroinflammation are thought to be fundamental in the etiology of MDD. To explore intermediary components that are modulated by stress and neuroinflammation, we exposed male C57BL/6 mice to 6 weeks of chronic unpredictable mild stress (CUMS) or 10 days of lipopolysaccharide (LPS) intraperitoneal injection to mimic depression. Depressive-like phenotypes in these models were validated by tail suspension tests (TSTs) (Can et al., 2012) , forced swimming tests (FSTs) (Chatterjee et al., 2012) , and sucrose preference tests (SPTs) ( Figures 1A and 1B ). We found that Men1 protein and Male C57BL/6 mice were exposed to chronic unpredictable mild stress (CUMS) or LPS induction. (A and B) CUMS-(A) and LPS-(B) treated mice and Ctrl mice behaviors in TSTs, FSTs, and SPTs (CUMS, n = 10 mice; Ctrl, n = 8 mice; LPS treated, n = 9 mice; Ctrl, n = 9 mice). (C and D) Men1 mRNA and protein levels in CUMS/control (C) and LPS-treated/control (D) mouse brains. n = 3 experimental replicates/group. (E and F) Cortical sections of CUMS/control (E) or LPS-treated/control (F) mouse brain, stained to visualize menin (green) with NeuN (red), GFAP (red), or IBA1 (red) as indicated to characterize menin expression in neurons, astrocytes, or microglia (scale bar, 100 mm). Staining intensity is quantified as shown in the lower panels. Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Turkey's post hoc test. See also Figures S1 and S2. mRNA levels are significantly attenuated in cortex from both CUMS-and LPS-treated mice by western blotting and . Immunostaining also revealed that menin is markedly decreased in neurons and astrocytes (arrows) in mouse brain after CUMS and LPS treatment. Menin expression was relatively low in microglia (arrows) and little difference in microglia abundance was observed with CUMS or LPS treatment ( Figures 1E and 1F ). The nucleus accumbens (NAc) is an important brain region in depression, where menin levels are also significantly decreased in NAc of CUMS mouse brain (Figure S1A) . These results suggest that menin may be involved in chronic stress, neuroinflammation, and consequent depressive-like phenotypes.
Generation of Men1 Brain Cell-Type-Specific Conditional Knockout Mice Men1 expression can be detected in most mouse organs from gestational day 7, including the brain (Matkar et al., 2013) . Comparing menin expression in cultured neurons, microglia, astrocytes, and oligodendrocytes ( Figure S2A ), we found that menin expression was relatively high in neurons and astrocytes. Interestingly, menin expression was most predominant in astrocytes (Figures S2B and S2C) . By immunostaining, we confirmed that very little menin can be detected in microglia and oligodendrocytes in mouse cortex (Figures 1E, 1F, and S2D) . MBP (myelin basic protein) staining also reveals no difference in myelination between astrocyte plus neural progenitor cell-specific (GcKO) and control (Ctrl) mouse cortex and hippocampus ( Figure S2E ). To investigate potential astrocyte-or neuron-specific effects associated with depressive-like phenotypes derived from Men1 gene deletion, we generated CNS-specific whole-brain (NcKO), neuron-specific (CcKO), and GcKO Men1 deletion mouse lines by crossing the floxed Men1 allele with Nestin-Cre, CamkIIa-cre, or GFAP-Cre transgenic lines (Akbarian et al., 2002; Scacheri et al., 2004; Tronche et al., 1999; Trumpp et al., 1999; Westerman et al., 2012) , respectively ( Figure 2A ). Global Men1 deletion in the CNS resulted in early postnatal lethality (Zhuang et al., 2018) ; therefore, we used heterozygous Men1 deletion strains generated by Nestin-Cre crosses (Nestin-Cre, Men1 f/+ ) for comparison. Men1 CcKO and GcKO animals exhibited normal growth rate; body and brain sizes, in addition to longevity, were indistinguishable from Ctrls (Men1 f/f animals were used as Ctrls) (Figures S3A-S3C) (Zhuang et al., 2018) . To confirm astrocyte-specific menin reduction in GcKO transgenic animals, we performed menin/glial fibrillary acidic protein (GFAP) and menin/NeuN double staining in GcKO brain cortex. GFAP-labeled astrocytes featured attenuated menin staining, while neuronal menin expression was minimally affected in GcKO mice compared to Ctrls . No appreciable differences in cortical structure were observed between GcKO and Ctrl mice by Nissl staining ( Figure S3G ). Altogether, these findings suggest that postnatal deletion of menin in brain has minimal effects on overall brain development in mice.
Mice with Astroglial Men1 Reduction Exhibit Depressive-like Behaviors
We then assessed potential depressive-like behaviors in Men1 NcKO, CcKO, and GcKO mice using TSTs (Can et al., 2012) , FSTs (Chatterjee et al., 2012) , SPTs, and sucrose consumption tests (SCTs) (Gross and Pinhasov, 2016) . Surprisingly, NcKO and GcKO mice showed a significant increase in immobility duration during TSTs and FSTs, whereas CcKO animals showed little or no variation compared to Ctrls (Figures 2B and 2C) . Furthermore, NcKO and GcKO animals exhibited less preference to sucrose in SPT and SCT trials, with no effect observed in CcKO animals ( Figures 2D-2F ). These results indicate that mice with menin reduction in astrocytes (NcKO and GcKO lines), but not in neurons (CcKO), manifest depressivelike phenotypes. Impaired social interactivity is also characteristically seen in MDD; social interactions in GcKO mice were also found to be impaired in the presence of novel interaction partners during social interaction tests (SITs) (Figures 2G and 2H) .
GcKO animals exhibited reduced general locomotion in open field tests and plus maze assays, with no differences observed in motor coordination in rotarod tests, and anxiety-like behavior in open field and elevated plus maze assays ( Figures S4A-S4C ). Since reduced locomotor activity may be due to depressive or motivational deficits in GcKO animals, we performed Morris water maze tests to further characterize cognitive behavior. GcKO mice did not exhibit significant differences in learning and memory, or swimming speed and distance compared to Ctrl mice ( Figures S4D and S4E ), indicating that astroglial reduction of menin had no effect on forced locomotor activity, anxiety, or learning and memory.
To further determine whether astrocytic menin is critical for depressive-like behaviors, we used an Fgfr3-iCre(ER) mouse line in which CreER is expressed from an Fgfr3 promoter and activation of the Cre recombinase is induced by tamoxifin, resulting in menin reduction in forebrain subventricular zone progenitor cells and astrocytes (Rivers et al., 2008) . Tamoxifin-induced astrocyte-specific Men1 KO mouse lines were generated by crossing Men1 f/f and Fgfr3-iCre(ER) mouse lines, hereby referred to as FcKO (Figure 2A ). Astroglial menin levels were substantially decreased in FcKO mice compared to Ctrls with tamoxifin treatment ( Figures S3H and S3I ), with no significant effects observed on brain weight ( Figure S3J ). As expected, FcKO mice also exhibited depressive-like phenotypes as determined by TST and FST trials ( Figure 2I ). Together, these results suggest that menin deficiency in astrocytes promotes depressive-like phenotypes in mice.
Astrocytic Menin Reduction Promotes IL-1b Production through NF-kB Activation
To explore molecular mechanisms associated with the phenotypes observed upon astrocyte Men1 reduction, we examined mRNA expression profiles by RNA sequencing (RNA-seq) analysis in primary cultured astrocytes derived from Ctrl and GcKO mice using a BGISEQ-500 platform. Altogether, 562 genes showed altered expression in 3/3 samples (>2-fold difference to Ctrls, FDR-corrected p < 0.001; Figure 3A ). GO biological process analysis indicates that cytokine-cytokine receptor interaction was significantly represented within the dataset ( Figure 3B , RED). This implicates potential modulation of the neuroinflammatory response with astroglial menin reduction.
Neuroinflammation is tightly associated with the onset of depression (Fenn et al., 2014; Skaper et al., 2014) . Given that astrocytic menin reduction results in depressive-like behaviors, it seems likely that astroglial neuroinflammatory mechanisms may drive depressive-like phenotypes in GcKO mice. As predicted, many pro-inflammatory factors including IL-1b were significantly upregulated in astrocytes derived from cortex of GcKO compared to Ctrl mice ( Figure 3C ). Given that IL-1b is a key pro-inflammatory cytokine involved in the induction of depressive-like behaviors (Koo and Duman, 2009; Norman et al., 2010) , we confirmed that IL-1b mRNA levels were indeed dramatically enhanced in cortex of GcKO and NcKO mice, but not in CcKO mice ( Figure 3D ). IL-1b mRNA levels were also enhanced in the NAc of CUMS mouse brain ( Figure S1B ). Next, we measured IL-1b levels in cultured primary astrocytes and neurons derived from cortex in Men1-NcKO mice and littermate Ctrls. In agreement with our results in vivo, we detected higher basal IL-1b mRNA levels in Ctrl astroglial cultures compared to Ctrl neuronal cultures ( Figure 3E ). Neuronal menin reduction did not affect IL-1b expression in neuronal cultures; (legend continued on next page) however, menin reduction in astrocytes resulted in an $2-fold increase in IL-1b expression (NcKO astrocytes compared to Ctrls; Figure 3E ). Elevations in astroglial IL-1b and reduced menin levels were further confirmed by measuring IL-1b levels in conditioned media from Ctrl and Men1 KO cortical or hippocampal astroglial cultures ( Figure 3F ), as well as cortical brain lysates from GcKO and Ctrl mice ( Figure 3G ). Microglia cells are sensitive to neuroinflammation and are fundamentally involved in the production of pro-inflammatory cytokines (Brambilla et al., 2005; Farina et al., 2007) . We observed enhanced activation of microglia in cortex of GcKO mice, with little or no change in proliferation ( Figures S5A and S5B ). Thus, microglial activation by astrocyte-derived pro-inflammatory cytokines likely exacerbates neuroinflammation in GcKO mice.
The IL-1b promoter region comprises classical NF-kB binding sites and has been well characterized as a downstream NF-kB target (Cogswell et al., 1994) . Since astrocytes have been shown to mediate inflammation through the NF-kB pathway (Herkenham et al., 2011; Mao et al., 2009) , we determined whether menin reduction can activate NF-kB in astrocytes. To test this, we measured NF-kB luciferase reporter activity in Men1-deficient astrocytes and observed a significant increase in NF-kB-mediated transactivation ( Figure 3H ). Conversely, menin overexpression in Men1-deficient astrocytes suppressed NF-kB-mediated transactivation ( Figure 3H ). Using an astrocytic cell line stably expressing menin (CHG-5-MEN1), we observed a decrease in IL-1b mRNA and protein levels, with attenuated NF-kB-mediated transactivation in CHG-5-MEN1 cells compared to CHG-5-vector Ctrls (Figures S6A-S6C). Similar results were observed in HEK293T cells: while menin overexpression inhibited NF-kB-mediated transactivation, MEN1 knockdown enhanced NFkB-mediated transactivation ( Figures S6D-S6F ). Additionally, menin overexpression inhibited NF-kB-mediated transactivation induced by LPS exposure ( Figure S6G ), further indicating that menin can suppress NF-kB-dependent transactivation.
Nuclear p65 translocation can directly enhance NFkB-mediated transactivation. To determine whether menin reduction affects nuclear p65 translocation, we examined changes in p65 distribution by comparing enriched nuclear and cytoplasmic fractions. No obvious difference in nuclear p65 distribution was observed in brain cortex comparing GcKO and Ctrl groups (Figure S6H) . Similarly, menin overexpression in CHG-5 cells also had no effect on nuclear p65 distribution ( Figure S6I ). These results suggest that menin deficiency does not affect p65 nuclear translocation.
Next, we determined whether menin directly affects p65/DNA binding. Significantly, menin overexpression decreased p65 binding activity as determined by electrophoretic mobility shift assay (EMSA), while Men1 knockdown conversely enhanced p65/DNA binding interactions ( Figures 3I and 3J ). Further, menin and p65 was co-immunoprecipitated from mouse brain tissue lysates ( Figure 3K ), indicating that menin and p65 could interact within a protein complex. Cytoplasmic menin showed no effect in inhibiting NF-kB-mediated transactivation; although cytoplasmic menin constructs (menin fused to a nuclear export signal, NES) showed interactions with p65, no effects on NF-kB were observed with these constructs ( Figure 3L ). In mapping the regions required for menin/p65 interaction, a 277-541 amino acid region in menin was found to be crucial for p65 binding; menin constructs lacking this region abolished menin-mediated inhibition on NF-kB-dependent transactivation ( Figure 3M ). These results suggest that menin suppresses NF-kB activation through its association with p65, thereby inhibiting p65-DNA binding.
NF-kB Inhibitor and IL-1b Receptor Antagonist Ameliorate Depressive-like Behaviors in GcKO Mice
To determine whether inhibiting the NF-kB/IL-1b pathway can rescue depressive-like behaviors in GcKO mice, we treated GcKO and Ctrl mice with an NF-kB inhibitor, pyrrolidine dithiocarbamate (PDTC), or an IL-1b receptor antagonist (IL-1b-RA) by intraperitoneal injection for 7 days ( Figure 4A ). We found that both PDTC and IL-1b-RA treatment significantly decreased immobility in GcKO mice in TST and FST trials , and rescued SPT and SCT behaviors (Figures 4F and 4G) in GcKO mice. Further, social interaction deficits were completely rescued by PDTC administration (Figures 4H and 4I) . IL-1b-RA significantly enhanced primary contact with novel mice, with no effects on a second novel mouse (Figures 4J and 4K) . Ctrl mice treated with PDTC or IL-1b-RA did not exhibit any significant behavioral differences in TST, FST, SIT, SPT, and SCT trials ( Figure 4) . These results indicate that PDTC and IL-1b-RA significantly rescued depressive-like behavioral deficits in GcKO mice, with little adverse side effects observed in Ctrls. (I and J) p65 DNA binding capacity was measured by EMSA in HEK293T cells after transfection with the plasmids indicated. Quantification of panels in (I) are shown in (J); n = 3 experimental replicates/group. (K) Menin/p65 interactions were measured in mouse brain by endogenous co-immunoprecipitation (coIP). (L) HEK293T cells were co-transfected with p65 together with GFP, GFP-MEN1, GFP-NES, GFP-NES-MEN1, or GFP-MEN1 (277-541) constructs. Interactions between p65 with menin were determined by coIP; antibodies used in the IP reactions are indicated. (M) NFkB-mediated transactivation in astrocytes transfected with plasmid constructs as indicated. Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey's post hoc analysis. See also Figure S1 , S5, and S6.
IL-1b-RA Rescues Neuronal Morphological Abnormalities and Synaptic Deficits Induced by Astroglial Menin Reduction
Astrocytes provide neurons with morphogenic and metabolic support and are fundamental to the functional regulation of dendritic spines (Allen, 2014) . Using a co-culture system comprising primary Ctrl or Men1 KO astrocytes cultured with Ctrl primary neurons, we assayed effects of astrocytic menin reduction on neuronal dendritic morphology, as indicated by microtubuleassociated protein 2 (MAP2) staining ( Figure 5A ). Interestingly, dendritic complexity and total length (Figures 5A and 5B) were reduced in neurons cultured with Men1 KO astrocytes. Ionotropic glutamate receptor subunits (GluR1 and NR2A) and synaptic components (postsynaptic density protein 95 [PSD95]) were also dramatically decreased in neurons co-cultured with Men1 KO astrocytes ( Figures 5C and 5D ). Importantly, treatment of Men1 KO astrocyte/neuron co-cultures with IL-1b-RA restored neuronal dendritic complexity, total dendritic length, and synaptic protein expression ( Figures 5A-5D ). Further, Golgi staining in GcKO mouse cortex and hippocampus revealed significant attenuation in dendritic branching, while IL-1b-RA treatment significantly improved dendritic complexity ( Figures 5E and 5F ). Expression of GluR1, NR2A, PSD95, and IL-1b levels was also restored in cortex and hippocampus of GcKO mouse brain ( Figure S7 ). Furthermore, microglia activation was attenuated ( Figures S5C and S5D) , indicating that attenuation of neuroinflammatory response in GcKO brain is ameliorated with IL-1b-RA treatment. Further, serotonin levels were markedly decreased in cortex of GcKO mice, while IL-1b-RA normalized serotonin levels ( Figure 5G ).
Dendritic arbor and complexity tightly correlate with neuronal function, and deficits in hippocampal neural plasticity are also associated with mouse models of depression (Castré n, 2013; Christoffel et al., 2011) . We compared hippocampal-dependent long-term potentiation (LTP) in acute brain slices derived from GcKO and Ctrl mice. Notably, LTP was dramatically impaired in GcKO mice compared with Ctrls. Moreover, LTP deficiencies were rescued by exposure to IL-1b-RA in cultured hippocampal slices by electrophysiological analysis (Figures 5H and 5I) . , control+normal saline group, n = 10 mice; control+NF-kB inhibitor group, n = 6 mice; GcKO+normal saline group, n = 7 mice; GcKO+NF-kB inhibitor group, n = 7 mice; (D) and (E), control+normal saline group, n = 11 mice; control+IL-1b-R-A group, n = 13 mice; GcKO+normal saline group, n = 6 mice; GcKO+IL-1b-RA group, n = 7 mice; (F) and (G), n = 8 mice for each group. (H-K) PDTC/saline-(H and I) or IL-1b-RA/saline-(J and K) treated GcKO and littermate Ctrls in social affiliation and sociability assays. Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey's post hoc analysis.
A MEN1 SNP Is Associated with MDD Risk Loss-of-function MEN1 gene mutations are commonly observed in MEN1 syndrome patients (Chandrasekharappa et al., 1997) .
To determine whether MEN1 mutations are associated with the development of MDD in humans, we genotyped the MEN1 coding region on chromosome 11q13.1 in a total of 1,032 patients with MDD and 866 Ctrls. Subjects with MDD and corresponding Ctrls were age-and sex-matched (Table 1) . Within the analyzed cohort, approximately 18% of the MDD patients reported MDD in multiple members within their family lineage. In nine SNPs identified within the MEN1 coding region (Table 2) , only one of these SNPs (T-allele of rs375804228) was associated with MDD susceptibility by chi-square test (c 2 = 7.236, p = 0.00715, odds ratio [OR] = 3.208, 95% confidence interval [95% CI], 1.37-7.50). The rs375804228 polymorphism resides on exon 10 in the Men1 locus, and the T-variant of this allele results in a G503D substitution (Table 2) . Two other SNPs, rs2071313 and rs2959656, are common polymorphisms, with a prevalence of approximately 20% and 42%, respectively (Concolino et al., 2016; Lemos and Thakker, 2008) (Table 2 ). The rs2071313 polymorphism resides on exon 9 and is a non-coding variant (D418D) (Bazzi et al., 2008) , while rs2959656 (A/G) results in a benign amino acid substitution (A541T) (Bazzi et al., 2008) .
To investigate the possibility that rs375804228 (G503D) is involved in MDD, we generated menin GFP-tagged wild-type (WT) and G503D (GFP-MEN1-G503D) expression vectors. GFP-MEN1-D418D and GFP-MEN1-A541T constructs were used as Ctrls. We observed no significant difference in MEN1 mRNA or protein expression levels in WT-and G503D-menin constructs (Figures S8A and S8B) . Moreover, we observed no difference in protein stability between WT-and G503D-menin using cycloheximide stability assays ( Figures S8C and S8D) ; similar results were observed in D418D (rs2071313) and A541T (rs2959656) constructs. Lastly, MEN1 mutation had no effect on menin nuclear localization ( Figure S8E ). Together, these results indicate that rs375804228 (G503D) does not alter transcription, protein expression, protein turnover, or cellular localization profiles in menin.
Since menin associates with p65 to inhibit NF-kB transactivation, we speculated that G503D may affect menin-p65 association. Indeed, MEN1-G503D abolished menin-p65 interaction, with little or no effect on p65 localization ( Figures 6A and S8F) . Furthermore, MEN1-G503D mutation abrogated its ability to suppress p65-DNA binding interactions ( Figure 6B) . Although re-expression of WT-, D418D-, or A541T-menin could restore NF-kB-mediated transactivation in HEK293T cells transfected with MEN1-targeting small interfering RNAs, G503D mutation abolished rescue effects associated with menin re-expression ( Figure 6C ). Notably, elevations in NF-kB-mediated transactivation in Men1-deficient mouse astrocytes derived from cortex were reduced by MEN1-WT, -D418D, or -A541T expression, whereas G503D constructs failed to reduce NF-kB hyperactivity ( Figure 6D ). Furthermore, in human primary astrocytes, we also confirm that G503D menin mutant constructs failed to rescue NF-kB hyper-activation with MEN1 downregulation with shMEN1 expression ( Figure 6E ). Finally, elevations in IL-1b expression from Men1-deficient mouse astrocytes were reduced by MEN1-WT, -D418D, or -A541T expression; G503D constructs failed to reduce IL-1b overexpression ( Figure 6F ). Altogether, these results implicate a role for G503D MDD menin variants in abrogating menin-dependent suppression of NF-kB hyper-activation and pro-inflammatory IL-1b generation.
DISCUSSION
Neuroinflammation (Maes, 1994; M€ uller, 2014) and pathological alterations in astrocytic function (Slavich and Irwin, 2014; Wang et al., 2017) have been previously reported in depressive disorders. As the most abundant cell type in the brain, astrocytes play a central role in mediating and regulating neuroinflammation (Farina et al., 2007) . However, molecular and cellular mechanisms underlying the regulation of astrocyte-mediated neuroinflammation in depression remain elusive. Here, we demonstrate that reduction of menin in astrocytes leads to a depressive-like phenotype, including despondent mood and social interactivity deficits. Increased neuroinflammation drives behavioral abnormalities in astroglial Men1-deficient mice. In addition, we identified a MEN1 SNP, rs375804228, that is associated with an elevated risk of MDD onset and leads to aberrant NF-kB activation and IL-1b production.
Microglia and astrocytes mediate the production of pro-inflammatory cytokines (Brambilla et al., 2005; Farina et al., 2007) , which drives the pathogenesis of depressive-like phenotypes (Fenn et al., 2014; Skaper et al., 2014) . In the CNS, astrocytes represent the most abundant cell type in the brain and feature prominent NF-kB activity (Herkenham et al., 2011; Yang et al., 2009 ). Activation of NF-kB is a common feature in MDD and other neurological conditions (Caviedes et al., 2017) , whereas NF-kB hyperactivity leads to the production of pro-inflammatory cytokines such as IL-1b, which is a key driver in the clinical manifestation of depressive symptoms. In addition to astrocytes, NF-kB is also expressed in microglia. Although our data directly indicate that NF-kB-mediated neuroinflammation in astrocytes results in depressive-like phenotypes, microglia may also similarly modulate neuroinflammation through NF-kB induction. Since menin levels are relatively low in microglia, the NF-kB pathway may be more sensitive to activation in microglia through menin-independent pathways. Furthermore, menindeficient astrocyte-derived pro-inflammatory factors also induce microglial activation, thereby leading to neuronal dysfunction through numerous microglial-derived factors. Further, the sum of our results indicates that astrocyte-specific Men1 deletion may be a useful model to study neuroinflammatory disorders.
Biological pathways mediated by pro-inflammatory cytokines in the pathogenesis of depression disorders include HPA (hypothalamic-pituitary-adrenal) axis dysfunction (Belvederi Murri et al., 2014; Krishnan and Nestler, 2008) , reduced serotonin levels (Frodl et al., 2010; Gatt et al., 2009) , and impaired neuroplasticity (Eyre and Baune, 2012; Yirmiya and Goshen, 2011) . Glucocorticoids are generated, regulated, and secreted by the HPA axis, and are elevated in serum from patients suffering from depression (Parker et al., 2003; Raison and Miller, 2003) . Further, serotonin levels were markedly decreased in Men1-deficient GcKO mice, while IL-1b-RA normalized serotonin levels ( Figure 5G ). Together, these results give strong indication that astrocytic menin can alter serotonin levels, which can have a visible impact on clinical depression. MDD was initially thought to be primarily triggered through neuronal dysfunction (Manji et al., 2001) . Indeed, depression has been shown to be induced by dysregulated mechanisms that influence synaptic plasticity in afflicted regions (Duman and Aghajanian, 2012) . Neuronal impairment in depression is associated with reduced dendritic complexity and spine number, as observed in postmortem brain samples from patients with depressive disorder and rodent stress models of depression (Rajkowska et al., 1999; Stockmeier et al., 2004) . We observed a substantial decrease in dendritic complexity in the cortex and hippocampus of GcKO mice.
Although our study mainly concentrated on the two major brain areas of cortex and hippocampus, other brain regions are also associated with depression. The NAc plays key roles in depression symptomatology including anhedonia and reduced motivation (Lim et al., 2012; Stuber et al., 2011) . We also observed that menin mRNA levels were markedly decreased in NAc of CUMS mouse brain, while IL-1b levels increased dramatically in NAc of GcKO mice ( Figure S1 ). Since menin is expressed throughout the entire brain, the effect of menin on neuroinflammation in other brain regions warrants further investigation. Given that our results show that IL-1b-RA can restore morphogenic deficits and hippocampal LTP impairment, NF-kB inhibitors and IL-1b-RA may represent potential treatment strategies to ameliorate inflammation-based depression disorders.
Etiologically, MDD is a complex disease that involves a combination of environmental and genetic factors (Bosker et al., 2011) . Cumulative evidence indicates that heritable genetic factors are associated with MDD (Hyde et al., 2016; Wray et al., 2012) . Numerous candidate genes have been characterized in association with depression (Hyde et al., 2016) and functional links between depression and genes regulating the serotonin or neurotrophin signaling have been implicated (Ló pez-Leó n et al., 2008; Nugent et al., 2011) . Despite strong evidence supporting the involvement of heritable components in MDD, efforts to clarify biological mechanisms through common or rare variant association studies have been unsuccessful. This has been attributed to heterogeneity of the disease and absence of established standards in clinical diagnosis. Recently, genome-wide association studies have implicated several SNPs associated with major depression (Hek et al., 2013; Lewis et al., 2010; Nugent et al., 2011; Sullivan et al., 2009 ). The human MEN1 gene is located at the 11q13.1 locus, Figure 6 . MDD-Associated G503D Menin Mutation Abrogates Menin/p65 Interactions and Menin-Dependent NF-kB Suppression (A) Interactions between p65 and WT menin or relevant menin mutations were determined in HEK293T cells by co-transfection with p65 and GFP Ctrl, GFP-MEN1, GFP-MEN1-D418D, GFP-MEN1-G503D, or GFP-MEN1-A541T constructs. n = 3 experimental replicates/group. Quantification of p65/menin coprecipitation is presented in the graph below. (B) p65 DNA binding activity measured by EMSA in HEK293T cells following transfection with the plasmids as indicated. n = 3 experimental replicates/group. Quantification is presented in the graph below. (C) NFkB-mediated transactivation in HEK293T cells following transfection with plasmid vectors as indicated. n = 3 experimental replicates/group. (D) NFkB-mediated transactivation in Ctrl or Men1-deficient astrocytes derived from mouse cortex transfected with vectors as indicated. n = 3 experimental replicates/group. (E) NFkB-mediated transactivation in human primary astrocytes transfected with vectors as indicated. n = 3 experimental replicates/group. (F) IL-1b levels in astrocytes derived from mouse cortex transfected with the vectors indicated as determined by ELISA. n = 4 experimental replicates/group. Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey's post hoc analysis. See also Figure S8 . and MEN1 gene mutations that normally inactivate this gene are commonly found in patients with MEN1 syndrome (Chandrasekharappa et al., 1997; Lemmens et al., 1997) . To date, approximately 1,500 MEN1 mutations have been reported in patients with endocrine disorders (Concolino et al., 2016; Lemos and Thakker, 2008) ; here, our results indicate that carriers of the MEN1 SNP rs375804228 G503D risk variant are associated with a higher risk of MDD onset. This is the first MEN1 gene mutation characterized outside of MEN1 syndrome and is unique among all MEN1 gene mutations reported previously. The majority of MDD patients are heterozygous carriers for the rs375804228 SNP and would therefore be predicted to manifest a partial loss of menin function, thereby triggering consequent NF-kB activation/inflammation in depressive onset. Our findings linking this menin-associated SNP to MDD could be utilized in early diagnosis of depression through diagnostic screening and implicate potential attenuation of the NF-kB pathway in personalized treatment strategies in patients diagnosed with menin-associated MDD. Our data also indicate that MEN1 syndrome patients with MEN1 mutations may also be at risk for MDD; future studies may indicate whether mutations associated with MEN1 syndrome can also affect MDD onset.
In summary, we have identified a distinct role for astrocytic menin in the onset of depression through neuroinflammatory pathways. These results also suggest that menin could also be a prognostic marker for depression disorders, which may be predictive of depressive symptoms and oncogenic potential.
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jie Zhang (jiezhang@xmu.edu.cn). , were also recruited as controls. Controls were recruited from local communities and information was disclosed regarding medical and family history. Controls comprised ages ranging 40.86 ± 14.06 (SD) years. Criteria to exclude patients within the control group include a history of major psychiatric or neurological disorders, psychiatric treatment or drug abuse, and/or family history of inherited severe psychiatric disorder. MDD and control subjects were respectively stratified into six subsets according to their age (< 21; 21-30, 31-40, 41-50, 51-60 and > 60) . 40% of the individuals were randomly sampled from each subset for analysis. All the subjects were of Chinese Han origin, and originated from Northern China. Detailed clinical information regarding the patients and controls are presented in Table 1 . Written informed consents were obtained from all patients and controls in this study, and approved by the Ethics Committee of Chinese Academy of Medical Sciences and Peking Union Medical College (014-2016).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects
Animals
All mice were maintained in the core animal facility at Xiamen University, and all experimental procedures involved were performed according to protocols approved by the Institutional Animal Care and Use Committee at Xiamen University. Mice were housed under a 12 h light/dark cycle with free access to standard rodent chow and water. Each cage housed a maximum of four mice. Mice were maintained under Specific-Pathogen-Free (SPF) conditions and were not subject to immunosuppression. Health of the animals used was regularly controlled by animal caretakers. All mice used in the study were not previously involved in other experimental procedures, and were free from other non-relevant exposure to drugs or tests. A mixture of 2 month old litter/age-matched male and female mice were employed in all studies and no differences between sexes were observed. Animals were used according to ''3Rs'' principles (Replacement, Reduction and Refinement) in all experimental procedures. In some experiments, animals were subjected to two experimental conditions with a single control group (Figures 4F and 4G) to minimize the number of animals used.
The floxed Men1 mouse strain was obtained from Dr. Guanghui Jin and Dr. Xianxin Hua (Crabtree et al., 2003) . Nestin-Cre, CamkIIa-cre, GFAP-Cre and Fgfr3-iCre(ER) transgenic mice (Scacheri et al., 2004; Tronche et al., 1999; Trumpp et al., 1999; Westerman et al., 2012) were obtained from Dr. Jiawei Zhou at the Institute of Neuroscience, Chinese Academy of Science; these mice are available from Jackson Laboratory. Men1-NcKO, CcKO, GcKO and FcKO mice were obtained by crossing Men1 floxed mice with respective Nestin-Cre, CamkIIa-cre, GFAP-Cre or Fgfr3-iCre(ER) mouse lines. Men1 floxed mice were used as controls. FcKO or control mice were treated with tamoxifin at 0.2 mg/g body weight or vehicle control by oral gavage once a day for five consecutive days. Tamoxifin was dissolved in 5% ethanol/corn oil at a final concentration of 50 mg/mL. Chronic Unpredictable Mild Stress (CUMS): C57BL/6 male wild-type mice were divided into control and CUMS groups. CUMS mice were maintained in individual cages. CUMS involved exposure to a variety of mild stressors: (i) 24h food deprivation, (ii) 24h water deprivation, (iii) 1h of exposure to an empty bottle, (iv) 7h cage tilt (45 ) cage (200 mL of water in 100 g of sawdust bedding), (vii) 30 min of forced swimming at 8 C, (viii) 2h of physical restraint, and (ix) 24h of exposure to a foreign object (e.g., a piece of plastic). These stressors were randomly scheduled over a 3 week period. LPS-induced mouse model: Male C57BL6/J mice (2 months) were intraperitoneally injected with LPS (Sigma, L-2880) dissolved in sterile 0.9% saline at 0.5mg/kg. This dosage was used to stimulate infection without inducing obvious inflammation or other maladies. Saline or LPS injection was administered between 09:00 and 09:30 a.m. daily for 10 days. Behavioral tests were performed 24 hours following the last injection. Brain tissue and serum was dissected/sampled 24h following behavioral testing for western blotting and ELISA experiments.
METHOD DETAILS
Experimental design
All experiments described in this study were performed a minimum of 3 times. We did not use a statistical method to predetermine the proper sample size. The sample size per experiment was determined according to previous publications. All the experiments involving cKO mice and relevant rescue experiments were performed and analyzed in a blind manner. Specifically, mouse genotype was de-identified during the experimental trials in the behavioral analyses described. Similarly, mice subjected to electrophysiological analysis (LTP) were identified by number where the genotype was withheld during electrophysiological recording. In our image analysis for neuronal morphology, images were acquired and genotype/treatment was de-identified in the image files for analysis.
Electrophysiology
For hippocampal slice recordings, 400 mm horizontal slices from control and GcKO mice were prepared using a Leica LS1200s vibrating microtome in ice cold oxygenated artificial cerebrospinal fluid (aCSF) (120 mM NaCl, 3.5 mM KCl, 1.25 Mm NaH 2 PO 4 , 26 mM NaHCO 3 , 10 mM D-glucose, 1.3 mM MgSO 4 , 2.5 mM CaCl 2 , PH = 7.4, 290-320 mOsm). Slices were transferred to a chamber and held at 32 C for 1 hour and at room temperature for an additional hour. All recordings were performed at room temperature. Mice were divided into three groups (Ctrl, GcKO with vehicle control, and GcKO with IL-1b-RA groups). IL-1b-RA was used at a concentration of 200 mg/ml.
Schaffer collateral inputs to the CA1 region were stimulated with a bipolar tungsten electrode. Field excitatory postsynaptic potentials (fEPSPs) were recorded from neurons within the CA1 dendritic layer by insertion of an electrode in the Schaffer collateral pathway as the stimulating electrode. Based on the stimulus-response curve, a stimulation intensity that evoked a fEPSP within 30% of the maximum response was selected and recorded for 20 min to establish a baseline. LTP was then induced with a two-train high-frequency stimulus (100 Hz-30 s interval). The field potential response following tetanic stimulation was recorded for 60 min. The LTP magnitude was quantified as the percentage change in the average fEPSP slope over 60 min after LTP induction.
MEN1 coding regions sequencing
Genomic DNA used for analysis was extracted from peripheral white blood cells using standard phenol-chloroform extraction methods. Coding exons of the MEN1 gene were confirmed using NCBI and Ensemble websites. MEN1 coding exons were amplified by PCR, and the PCR products were bi-directionally characterized by Sanger sequencing (Sino Geno Max Company, Beijing, China). Primers were designed using NCBI BLAST, and synthesized by Idobio Biological Technology (Beijing, China).
Behavioral Studies Forced Swimming Test
The forced swim test (FST) was used to assess depressive-like behavior. Mice were placed in a container filled with water that eventually resulted in immobility, reflecting behavioral despair. Water (23 ± 1 C) was placed in a transparent acrylic cylinder bath (10cm in diameter, 20cm in height) filled to a depth of 13cm. Mice were placed in the water for six minutes using a video tracking system (Smart 3.0); immobility duration (%) within the final 5 min of testing was recorded.
Tail Suspension Test
Mice were suspended by their tails from an acrylic bar (15cm in diameter, 30cm in height) for six minutes and monitored using a video tracking system (Smart 3.0). Escape-related behavior was assessed, where immobility duration (%) during the 6 min suspension period was recorded.
Social Interaction
The test apparatus for social interaction comprised three rectangular chambers (18 3 35 3 18 cm) divided by plexiglass walls with openings (6 3 5 cm) which allowed animals to move between chambers. Both side chambers contained an empty transparent plexiglass holder (8 cm in diameter, 10 cm high), with small holes allowing snout contact. The width of the holes were of a sufficiently small size to prevent biting or aggressive interactions between the animals. A test mouse was first released into the central chamber and was allowed to habituate for 5 min. An unfamiliar gender-and age-matched stranger mouse was then placed in one of the holders. The location of the stranger mouse in either of the two holders (the social chamber) varied systematically between trials. The test mouse was allowed to explore the apparatus for 10 min. At the end of the 10 min duration, a novel mouse was placed in the other holder. The test mouse was allowed to explore the entire apparatus for 10 min. Time spent in sniffing each holder was recorded using a video camera. Sucrose Preference Test (SPT) and Sucrose Consumption Test (SCT) Animals were first trained to consume a 1% sucrose solution from two differing bottles (48 hours before the formal experiment). Twenty-four hours later, the animals were allowed free access to 1% sucrose and water from two differing bottles. To avoid bottle side preference, the two bottles were switched. The amounts in the two bottles were measured after 24 hours and sucrose preference was calculated according to the following formula: Sucrose preferences (%) = sucrose consumption / (sucrose + water consumption) 3 100%.
Rotarod Test
Mice were placed on a stationary rotarod (AccuRotor Rota Rod Tall Unit, 63-cm fall height, 30-mm diameter rotating dowel; Accuscan, Columbus, OH). The dowel was then accelerated to 60 rpm/min, and the latency to fall (in seconds) was recorded. The procedure was repeated over 4 consecutive trials, which was averaged to yield the daily latency to fall for each mouse. If an animal fell off the rotarod rapidly (e.g., due to inattention or slips), they were placed back on the rotarod for an additional trial, and the latency was not included in the daily average. The entire procedure was repeated for 2 additional days for a total of 3 days. In addition to the average latency across the 4 trials per day, the maximum latency to fall per day was also analyzed.
Open Field Test
To explore locomotion and spontaneous activity, we characterized mouse behavior as they freely explored an open-field plastic chamber (40-cm width 3 40-cm length 3 30-cm height) using a video tracking system (Smart 3.0). Two month old mice were placed in this arena for 10 min., and total distance and time spent in the center region (20cm 3 20cm) was recorded.
